The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Circulation

• Publication date

  2006-12-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.106.655688PMID 17179034
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Smoking cessation for the secondary prevention of coronary heart disease.

  2012cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

  2007cited by this paper
• ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention

  2006cited by this paper
• You need hands

  2006cited by this paper
• Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic : the Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial ( ALLHAT )

  2006cited by this paper
• ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention).

  2006cited by this paper
• ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention

  2006cited by this paper
• Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials.

  2006cited by this paper
• Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial.

  2006cited by this paper
• Secondary Prevention of Macrovascular Events in Patients With Type 2 Diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macro Vascular Events): A Randomised Controlled Trial

  2006cited by this paper
• Bivalirudin for patients with acute coronary syndromes.

  2006cited by this paper
• ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention—summary article: A report of the American college of cardiology/American heart association task force on practice guidelines(ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention)

  2006cited by this paper
• Images in cardiovascular medicine. Bidirectional ventricular tachycardia caused by digitalis toxicity.

  2006cited by this paper
• Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.

  2006cited by this paper
• International nifedipine trial on antiatherosclerotic therapy (intact)

  2005cited by this paper
• The cardiovascular continuum and renin–angiotensin–aldosterone system blockade

  2005cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

  2005cited by this paper
• Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

  2005cited by this paper
• Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.

  2005cited by this paper
• The effect of cardiac resynchronization on morbidity and mortality in heart failure.

  2005cited by this paper
• Unchain my heart: the scientific foundations of cardiac repair.

  2005cited by this paper
• Effects of estrogen with and without progestin on urinary incontinence

  2005cited by this paper
• Insulin resistance and the metabolic syndrome

  2005cited by this paper
• 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial.

  2005cited by this paper
• Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II).

  2005cited by this paper
• Myocardial regeneration with bone‐marrow‐derived stem cells

  2005cited by this paper
• Something old, something new: beta blockers and clopidogrel in acute myocardial infarction.

  2005cited by this paper
• CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke

  2005cited by this paper
• EGF receptor activated by HB-EGF is required to calcium influx and vasoconstriction induced by endothelin-1

  2005cited by this paper
• Distal Microcirculatory Protection During Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Trial

  2005cited by this paper
• Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

  2005cited by this paper
• High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.

  2005cited by this paper
• Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled tri

  2005cited by this paper
• Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

  2005cited by this paper
• Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.

  2005cited by this paper
• Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial.

  2005cited by this paper
• Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.

  2005cited by this paper
• Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.

  2005cited by this paper
• Effects of Candesartan on the Development of a New Diagnosis of Diabetes Mellitus in Patients With Heart Failure

  2005cited by this paper
• Unfractionated and Low-Molecular-Weight Heparin as Adjuncts to Thrombolysis in Aspirin-Treated Patients With ST-Elevation Acute Myocardial Infarction: A Meta-Analysis of the Randomized Trials

  2005cited by this paper
• Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

  2005cited by this paper
• Early invasive versus selectively invasive management for acute coronary syndromes.

  2005cited by this paper
• Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.

  2005cited by this paper
• The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke

  2005cited by this paper
• Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.

  2005cited by this paper
• Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.

  2005cited by this paper
• Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality

  2005cited by this paper
• Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

  2004cited by this paper
• Surrogate markers for cardiovascular disease: structural markers.

  2004cited by this paper
• Heart-kidney interactions in ischemic syndromes.

  2004cited by this paper
• One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent: The TAXUS-IV Trial

  2004cited by this paper
• Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial.

  2004cited by this paper
• Surrogate Markers for Cardiovascular Disease: Functional Markers

  2004cited by this paper
• Genetic markers: progress and potential for cardiovascular disease.

  2004cited by this paper
• Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.

  2004cited by this paper
• Intravenous glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: lessons from recently conducted randomized clinical trials.

  2004cited by this paper
• ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).

  2004cited by this paper
• Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study

  2004cited by this paper
• Treatment of pulmonary arterial hypertension.

  2004cited by this paper
• Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

  2004cited by this paper
• Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

  2004cited by this paper
• Angiotensin-converting-enzyme inhibition in stable coronary artery disease.

  2004cited by this paper
• Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project.

  2004cited by this paper
• Development of diabetes is retarded by ACE inhibition in hypertensive patients – a subanalysis of the Captopril Prevention Project (CAPPP)

  2004cited by this paper
• Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure.

  2004cited by this paper
• Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study

  2004cited by this paper
• Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS)

  2004cited by this paper
• A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

  2004cited by this paper
• ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).

  2004cited by this paper
• Introduction to surrogate markers.

  2004cited by this paper
• Inflammation and Atherosclerosis

  2004cited by this paper
• ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients Wi

  2004cited by this paper
• Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.

  2004cited by this paper
• The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial.

  2004cited by this paper
• Beneficial Cardiovascular Pleiotropic Effects of Statins

  2004cited by this paper
• Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis

  2004cited by this paper
• The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.

  2004cited by this paper
• Established and emerging plasma biomarkers in the prediction of first atherothrombotic events.

  2004cited by this paper
• National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section

  2004cited by this paper
• Catheter ablation for atrial fibrillation in congestive heart failure.

  2004cited by this paper
• Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

  2004cited by this paper
• Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.

  2004cited by this paper
• Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

  2004cited by this paper
• Statin therapy is associated with lower mortality among patients with severe heart failure.

  2004cited by this paper
• Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials.

  2004cited by this paper
• Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis.

  2003cited by this paper
• Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial.

  2003cited by this paper
• A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

  2003cited by this paper
• Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure.

  2003cited by this paper
• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.

  2003cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial.

  2003cited by this paper
• Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

  2003cited by this paper
• The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.

  2003cited by this paper
• Randomized Comparison of Distal Protection With a Filter-Based Catheter and a Balloon Occlusion and Aspiration System During Percutaneous Intervention of Diseased Saphenous Vein Aorto-Coronary Bypass Grafts

  2003cited by this paper
• Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy.

  2003cited by this paper
• Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

  2003cited by this paper
• Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

  2003cited by this paper
• Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

  2003cited by this paper
• MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

  2003cited by this paper

• Factors influencing cardiovascular disease screening uptake and implementation strategies to enhance cardiovascular disease screening uptake in Singapore adults: a multi-method study protocol

  2026cites this paper
• Cardiovascular Science, Medicine, and Society: The Brave New World: The ACC Braunwald Lecture 2025.

  2026cites this paper
• Nup93-Mediated RNA Alternative Splicing Associated With Diabetic Atherosclerosis

  2025cites this paper
• Iontronic pressure sensor with a wide linearity range for "plug-and-play" fingertip pulse recording and statistical cardiovascular monitoring.

  2025cites this paper
• Assessment of oxidative stress and trace element dynamics in acute myocardial infarction and heart failure: a focus on zinc, copper, and thiol dynamics

  2025cites this paper
• Analysis of dietary pattern effects on metabolic risk factors using structural equation modeling

  2025cites this paper
• Mathematical Modeling of Capillary Dilation in Microcirculation Disorders in the Microcirculatory Bed of the Human Circulatory System

  2025cites this paper
• Long working hours at midlife and arterial stiffness at older age in a 24-year prospective cohort

  2025cites this paper
• Mitochondrial Dysfunction and Atherosclerosis: The Problem and the Search for Its Solution

  2025cites this paper
• Mitochondrial Dysfunction in the Cardiovascular Disease Continuum: Problems of Studying the Progression During the Follow-Up of the Pathologies

  2025influential citation
• Arterial stiffness and vascular aging: mechanisms, prevention, and therapy

  2025cites this paper
• Impact of IKCa Channels on CD34+ Cells in Arteriole Remodeling in Angiotensin II-Induced Hypertension Model Mice.

  2025cites this paper
• Cardiovascular benefits of semaglutide: a systematic review and meta-analysis of randomized controlled trials

  2025cites this paper
• Thiol/Disulfide Homeostasis in Pericardial Fluid and Plasma of Patients Undergoing Coronary Artery Bypass Surgery

  2025cites this paper
• Association of Parvovirus B19 with NLRP3 Inflammasome in Cardiovascular Diseases

  2025cites this paper
• Repeated exposure to psychosocial work-related factors and arterial stiffness among aging workers

  2025cites this paper
• Reduced abundance of Fusobacterium signifies cardiovascular benefits of sodium glucose cotransporter 2 inhibitor in type 2 diabetes: a single arm clinical trial

  2025cites this paper
• Sex and population differences in the cardiometabolic continuum: a machine learning study using the UK Biobank and ELSA-Brasil cohorts

  2024cites this paper
• Mathematical Modeling of Microcirculation Disorders in the Human Circulatory System

  2024cites this paper
• Mercury-mediated neurological diseases: insight into molecular mechanisms, mutant proteins, and structure-based therapeutic inhibitors

  2024cites this paper
• Updates on the Renin–Angiotensin–Aldosterone System and the Cardiovascular Continuum

  2024cites this paper
• Continuidad asistencial entre cardiología y AP en pacientes con cardiopatía isquémica crónica: diseño del estudio CAPRICI

  2024cites this paper
• Assessing the association between e-cigarette use and cardiovascular disease: A meta-analysis of exclusive and dual use with combustible cigarettes.

  2024cites this paper
• Correlations of Serum Lipid Parameters and Atherogenic Indices With Left Ventricular Diastolic Dysfunction Among Apparently Healthy Patients With Type 2 Diabetes Mellitus: A Multicenter In-Hospital Cross-Sectional Study

  2024cites this paper
• Mitochondrial Dysfunction and Risk Factors for Noncommunicable Diseases: From Basic Concepts to Future Prospective

  2024cites this paper
• Blood Homocysteine Levels Mediate the Association Between Blood Lead Levels and Cardiovascular Mortality

  2024cites this paper
• High free sugars, insulin resistance, and low socioeconomic indicators: the hubs in the complex network of non-communicable diseases in adolescents

  2024cites this paper
• Potential Effects of Sacubitril/Valsartan on the Cardio-ankle Vascular Index in Hypertensive Patients

  2024cites this paper
• Urate Levels as a Predictor of the Prevalence and Level of Cardiovascular Risk Factors: An Identificación de La PoBlación Española de Riesgo Cardiovascular y Renal Study

  2024cites this paper
• Association between ischemic heart disease and dietary intake of lycopene: a case–control study

  2024cites this paper
• Prospective associations between systolic blood pressure, serum cholesterol, and physical activity behaviour and the development of cardiovascular disease.

  2024cites this paper
• Achievement of LDL-Cholesterol Goals in Patients Receiving LLT in Primary Care: TERESA-AP Study

  2024cites this paper
• The effect of endurance (low intensity) training on managing the risk and progression of CVD in middle-aged adults: a systematic review

  2024cites this paper
• Aerobic exercise attenuates dysautonomia, cardiac diastolic dysfunctions, and hemodynamic overload in female mice with atherosclerosis

  2024cites this paper
• Association of meal-specific protein intake and cardiometabolic risk factors: a cross-sectional study

  2023cites this paper
• Spatial and temporal trends of overweight/obesity and tobacco use in East Africa: subnational insights into cardiovascular disease risk factors

  2023influential citation
• Genetic Deletion of the LINC00520 Homolog in Mouse Aggravates Angiotensin II-Induced Hypertension

  2023cites this paper
• Non-Conventional Risk Factors: “Fact” or “Fake” in Cardiovascular Disease Prevention?

  2023cites this paper
• Intrarenal Renin-Angiotensin System Activation Alters Relationship Between Systolic Blood Pressure and Progression of Chronic Kidney Disease

  2023cites this paper
• Evaluation of cadmium and mercury on cardiovascular and neurological systems: Effects on humans and fish

  2023cites this paper
• Quercetin and Heart Health: From Molecular Pathways to Clinical Findings

  2023cites this paper
• Development of risk prediction model for cognitive impairment in patients with coronary heart disease: A study protocol for a prospective, cross-sectional analysis

  2023cites this paper
• A Retrospective Observational Real-Word Analysis of the Adherence, Healthcare Resource Consumption and Costs in Patients Treated with Bisoprolol/Perindopril as Single-Pill or Free Combination

  2023cites this paper
• How should we assess the cardiovascular system in patients presenting with bothersome nocturia? ICI‐RS 2023

  2023cites this paper
• Thiol-based cardioprotection

  2023cites this paper
• Knowledge, awareness, and attitude among pharmacists regarding the risk estimation of cardiovascular disease in Jordan: Immersion of lipid-lowering agents

  2023cites this paper
• Regulatory Mechanisms in Biosystems

  2023cites this paper
• Genetic outline of the hermeneutics of the diseases connection phenomenon in human

  2023cites this paper
• The Association of HIV-Specific Risk Factors with Cardiovascular Events in Addition to Traditional Risk Factors in People Living with HIV

  2023cites this paper
• Contemporary aetiology of acute heart failure in a teaching hospital in Ghana

  2023cites this paper
• Progress on Physical Field‐Regulated Micro/Nanomotors for Cardiovascular and Cerebrovascular Disease Treatment

  2023cites this paper
• Cardio-Vascular Interaction Evaluated by Speckle-Tracking Echocardiography and Cardio-Ankle Vascular Index in Hypertensive Patients

  2022cites this paper
• Pathways in the association between added sugar consumption, obesity in mother-child dyads, and chronic oral disease burden in early childhood.

  2022cites this paper
• Insulin resistance phenotype is associated with vascular risk phenotype at the end of the second decade of life: a population-based study

  2022cites this paper
• Morphology and specifics of morphometry of lungs and myocardium of heart ventricles of cattle, sheep and horses

  2022cites this paper
• Bioconversion of lovastatin to simvastatin by Streptomyces carpaticus toward the inhibition of HMG‐CoA activity

  2022cites this paper
• Intersection of the Ubiquitin–Proteasome System with Oxidative Stress in Cardiovascular Disease

  2022cites this paper
• Impact of hypoglycemia at the time of hospitalization for heart failure from emergency department on major adverse cardiovascular events in patients with and without type 2 diabetes

  2022cites this paper
• Development of a diet pattern assessment tool for coronary heart disease risk reduction

  2022cites this paper
• Envelhecimento Vascular e Rigidez Arterial

  2022cites this paper
• Cholecalciferol supplementation lowers leptin and TMAO but increases NO and VEGF-A levels in obese vitamin D deficient patients: Is it one of the potential cardioprotective mechanisms of vitamin D?

  2022cites this paper
• Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes

  2022cites this paper
• Telomere length is associated with intima‐media thickness in pediatric liver transplant patients: A prospective cohort study

  2022cites this paper
• Translational insights from single-cell technologies across the cardiovascular disease continuum.

  2021cites this paper
• Serum potassium variability as a predictor of clinical outcomes in patients with cardiorenal disease or diabetes: a retrospective UK database study

  2021cites this paper
• Systemic circulating inflammatory burden and periodontitis in adolescents

  2021cites this paper
• Reciprocal organ interactions during heart failure: a position paper from the ESC Working Group on Myocardial Function

  2021cites this paper
• Biomimetic Nano drug delivery carriers for treating cardiovascular diseases.

  2021cites this paper
• The Potential Role of Soluble Angiotensin Converting Enzyme 2 As A Left Ventricular Dysfunction Biomarker

  2021cites this paper
• Oral GLP-1 analogue: perspectives and impact on atherosclerosis in type 2 diabetic patients

  2021cites this paper
• Retinal microvasculature impairments in patients with coronary artery disease: An optical coherence tomography angiography study

  2021cites this paper
• Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes

  2021cites this paper
• Protective effects of SGLT-2 inhibitors across the cardiorenal continuum: two faces of the same coin.

  2021cites this paper
• Můžeme snížit riziko rekurentního infarktu myokardu?

  2021cites this paper
• Morphological and morphometrical characteristics of cattle heart structure

  2021cites this paper
• Evaluating the thermal performance of a balloon-based renal sympathetic denervation system with array electrodes: a finite element study

  2021cites this paper
• A Systematic Review and Meta-Analysis of Prevalence of Obstructive Sleep Apnea in Iranian Patients with Cardiovascular Disease: Perspective of Prevention, Care and Treatment

  2021cites this paper
• Thoracic Aortic Calcification and Pre-Clinical Hypertension by New 2017 ACC/AHA Hypertension Guidelines

  2021cites this paper
• Cardiometabolic Risk Reduction: A Review of Clinical Guidelines and the Role of SGLT-2 Inhibitors.

  2021cites this paper
• Yoga and Lifestyle Factors in Heart Disease

  2021cites this paper
• Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value

  2021cites this paper
• Change of concentration of biochemical markers of dysfunction of endothelium at intake of inhibitors of tyrosinekinase of I and II generations at patients with a chronic myeloid leukemia as risk factor of development of cardiovascular complications

  2021cites this paper
• Regional Comparisons of Associations Between Physical Activity Levels and Cardiovascular Disease: The Story of Atlantic Canada

  2021influential citation
• Orthostatic Hypotension in Older Adults

  2021cites this paper
• Signalling mechanisms in the cardiovascular protective effects of estrogen: With a focus on rapid/membrane signalling.

  2021cites this paper
• Modern concept — renal continuum (acute kidney injury, acute kidney disease, chronic kidney disease)

  2021cites this paper
• Performances on the Montreal Cognitive Assessment Along the Cardiovascular Disease Continuum.

  2021cites this paper
• Monitoring of risk factors of cardiovascular diseases in adult men

  2021cites this paper
• Approach to the cardiometabolic continuum. Narrative description

  2021cites this paper
• Analysis of central macular thickness and choroidal thickness changes in patients with cardiovascular risk factors

  2020cites this paper
• THE BRANCHED-CHAIN AMINO ACID TRANSAMINASE 1 -23C/G POLYMORPHISM CONFERS PROTECTION AGAINST ACUTE CORONARY SYNDROME.

  2020cites this paper
• Drug adjustment of modified risk factors as one of the leading strategies for managing patients with cardiovascular diseases

  2020cites this paper
• Does healthy obesity exist in the elderly? Findings from the Northern Shanghai Study.

  2020cites this paper
• Approach to the cardiometabolic continuum. Narrative description.

  2020cites this paper
• The great debate : does it matter how you lower blood pressure?

  2020cites this paper
• Stabil Angina Pektoris Hastalarında Tiyol/Disülfid Homeostazı Analizi

  2020cites this paper
• Vascular Aging and Arterial Stiffness in Older Adults

  2020cites this paper
• Flow field study of radiofrequency ablation of renal sympathetic nerve: Numerical simulation and PIV experiments

  2020cites this paper
• Epigenetics and Vascular Senescence–Potential New Therapeutic Targets?

  2020cites this paper
• Serum potassium as a predictor of adverse clinical outcomes in patients with increasing comorbidity burden

  2020cites this paper